Comparison of eradication rates of moxifloxacin-rifabutin triple therapy and bismuth quadruple therapy as second-line regimens in patients with peptic ulcers.
Health Sci Rep
; 5(5): e780, 2022 Sep.
Article
en En
| MEDLINE
| ID: mdl-36032516
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Guideline
/
Observational_studies
Idioma:
En
Año:
2022
Tipo del documento:
Article